The aim was to analyze the risk of hip fracture in German primary care patients with dementia. This study included patients aged 65-90 from 1072 primary care practices who were first diagnosed with dementia between 2010 and 2013. Controls were matched (1:1) to cases for age, sex, and type of health insurance. The primary outcome was the diagnosis of hip fracture during the three-year follow-up period. A total of 53,156 dementia patients and 53,156 controls were included. A total of 5.3% of patients and 0.7% of controls displayed hip fracture after three years. Hip fracture occurred more frequently in dementia subjects living in nursing homes than in those living at home (9.2% versus 4.3%). Dementia, residence in nursing homes, and osteoporosis were risk factors for fracture development. Antidementia, antipsychotic, and antidepressant drugs generally had no significant impact on hip fracture risk when prescribed for less than six months. Dementia increased hip fracture risk in German primary care practices.
Introduction
Dementia is a psychiatric disorder caused by neurodegeneration and characterized by a progressive loss of cognitive functions leading to an alteration in the daily life of the patient (WHO, 2015) . There are 47.5 million people with dementia in the world and this number is set to increase to 75.6 million by 2030 and then exceed 130 million by 2050 (WHO, 2015) . In Germany, dementia affects around 1.2 million people, particularly women and the elderly, and approximately 200,000 new cases are diagnosed each year (Tunstall, 2015) . The average cost related to this mental illness exceeds E43,000 per patient per year, with almost 68% of this amount paid by caregivers and families (Tunstall, 2015) . Therefore, dementia has a significant impact on patients and their relatives, underlining the importance of adapted treatments and management for this disease in Germany.
Dementia has been acknowledged as a major risk factor for fall and bone fracture for decades. In 1988, Tinetti and colleagues demonstrated in 336 subjects aged 75 years and over monitored for a period of one year that cognitive impairments increased the risk of falling by five times (OR ¼ 5.0, 95% CI: 1.8-13.7) (Tinetti, Speechley, & Ginter, 1988) . Another study of falls and fractures in 157 patients with dementia demonstrated that 50% of patients fell or were unable to walk during the three-year follow-up period (Buchner & Larson, 1987) . More interestingly, the same work showed that the fracture rate was equal to 69 per 1000 persons per year, whereas this rate was more than three times lower in a nondementia sample matched for sex and age (Buchner & Larson, 1987) . These results were corroborated in 2014 by Wang et al. in a study of 1408 Taiwanese patients and 7040 randomly selected Taiwanese controls (Wang et al., 2014) . Indeed, these authors found that 18.75% of patients and 15.60% of controls developed hip fractures during a three-year follow-up period, and that the fracture risk associated with dementia was almost equal to 2 (HR ¼ 1.92, 95% CI: 1.48-2.49). Finally, another study published the same year showed in a cohort of 66,797 patients with fracture and 133,594 controls that the overall incidence rate of dementia in subjects with fracture was 41% higher than in individuals without fractures (6.05 versus 4.30 per 1000 persons per year) (Tsai et al., 2014) .
Although the close relationship between fracture risk and dementia has been shown by several authors in various countries (Buchner & Larson, 1987; Reyes et al., 2014; Seitz et al., 2014; Tinetti et al., 1988; Tsai et al., 2014; Wang et al., 2014) , no study has recently been conducted in Germany on this topic. Therefore, the goal of our work was to analyze the risk of hip fracture in patients with dementia in German primary care practices.
Methods Database
The Disease Analyzer database (IMS HEALTH) compiles drug prescriptions, diagnoses, basic medical and demographic data obtained directly and in anonymous format from computer systems used in the practices of general practitioners (Becher, Kostev, & Schro¨der-Bernhardi, 2009 ). Diagnoses (ICD-10), prescriptions (Anatomical Therapeutic Chemical Classification System), and the quality of reported data have been monitored by IMS based on a number of criteria (e.g., completeness of documentation, linkage between diagnoses and prescriptions).
In Germany, the sampling methods used for the selection of physicians' practices were appropriate to obtain a representative database of primary care practices (Becher et al., 2009) . Prescription statistics for several drugs were very similar to data available from pharmaceutical prescription reports (Becher et al., 2009 ). The age groups for given diagnoses in Disease Analyzer also agreed well with those in corresponding disease registries (Becher et al., 2009 ).
Study population
This study included patients aged between 65 and 90 from 1072 primary care practices who were first diagnosed with dementia during the index period (January 2010 to December 2013). Follow-up lasted three years and finished in April 2015. Patients were excluded if they had been diagnosed with fracture (ICD-10: M80, S02, S12, S22, S32, S42, S52, S62, S72, S82, S92, T02, T08, T10, T12) prior to dementia diagnosis (index date). A total of 53,156 dementia patients were selected after these exclusion criteria were applied. Finally, 53,156 nondementia controls free of any fracture diagnosis prior to index date were chosen and matched (1:1) to dementia cases for age, sex, and type of health insurance (private or statutory).
Study outcome
The primary outcome was diagnosis of hip fracture (ICD-10: S72) recorded in the database between the index date and the end of follow-up. Osteoporosis (M80, M81), diabetes (E10-E14), and visual disturbances (H53, H54), which are potentially associated with fracture risk, were determined based on primary care diagnoses (ICD-10 codes). Stroke (I63, I64, G45) and heart failure (I50) were also included in the regression model. Finally, the presence of medications used in dementia therapy, such as antidementia drugs, antipsychotics, and antidepressants, was also assessed. We considered five different prescription durations for these three variables: 1, 2, 3-5, 6-10, and more than 10 months.
Statistical analyses
Descriptive statistics were obtained and differences in subject characteristics (dementia versus controls) assessed using Wilcoxon tests for paired samples or McNemar's tests. Fracture-free survival analyses were carried out using Kaplan-Meier curves and log-rank tests. Cox proportional hazard models (dependent variable: incident fracture) were used to adjust for confounders. P-values < 0.05 were considered statistically significant. Analyses were carried out using SAS version 9.3.
Results

Patient characteristics
Patient characteristics are displayed in Table 1 . A total of 53,156 subjects were included in both dementia and control groups. The mean age was 81.3 years (SD ¼ 5.9 years) and 39.0% of subjects were men. A total of 7.3% of patients and matched controls had private health insurance. The proportion of subjects resident in nursing homes differed significantly between the dementia and control groups (18.2% versus 3.2%, p-value < 0.001). Diabetes, osteoporosis, and heart failure were slightly more common in nondementia subjects than in dementia patients (30.4% versus 29.4%, 10.9% versus 9.8%, and 21.1% versus 18.6%, respectively, all p-values < 0.001), whereas stroke occurred more frequently in the dementia group than in the control group (8.6% versus 7.2%, p-value < 0.001). Furthermore, antidementia drugs were given selectively to 13.5% of dementia patients, with 4.4% of them receiving one prescription and 9.1% at least two prescriptions. Finally, antipsychotics and antidepressants were more frequently used in dementia subjects than in matched controls (29.4% versus 8.3% and 24.9% versus 17.7%, both p-values < 0.001).
Share of patients with fracture diagnosis
Kaplan-Meier curves for time to hip fracture diagnosis in dementia and control groups are displayed in Figure 1 . A total of 2.0% of dementia patients and 0.4% of matched controls developed hip fracture after one year of follow-up (p p < 0.001). Bone fractures were presented in 5.3% of the dementia group and 0.7% of the control group after the three- year follow-up period (p < 0.001). Figure 2 shows Kaplan-Meier curves for time to hip fracture diagnosis in dementia patients in nursing home and home care settings. A total of 4.1% of dementia patients living in nursing homes and 1.5% of those living in their own homes displayed bone fracture after one year of follow-up (p < 0.001). A total of 9.2 and 4.3%, respectively, developed fractures at the end of follow-up (p < 0.001). The results of the multivariate Cox regression model for fracture diagnosis in dementia patients and matched controls are shown in 
Discussion
In our study, we demonstrated that dementia was associated with an increase in the risk of hip fracture in primary care practices in Germany. We also found that dementia subjects living in nursing homes had a higher chance of developing bone fracture than dementia patients living at home. Furthermore, we showed that osteoporosis increased the odds of fracture. Finally, when there were less than six prescriptions, antidementia, antipsychotic, and antidepressant drugs usually had no significant effect on this risk. The two main types of dementia are Alzheimer's disease, which accounts for 60-80% of all cases, and vascular dementia, which is found in approximately one out of five patients with dementia (Reitz, Brayne, & Mayeux, 2011; Rizzi, Rosset, & Roriz-Cruz, 2014) . In a 2005 study of 245 subjects aged 65 years and over, Allan and colleagues found that dementia patients had a higher risk of gait and balance disorders than controls (Allan, Ballard, Burn, & Kenny, 2005) . Therefore, dementia subjects are at a higher risk of falling and developing bone fracture. Indeed, a study which included 2015 dementia patients and controls from 59 nursing homes has demonstrated that the fall rate per year was 4.05 in the dementia group as against 2.33 in the control group (RR ¼ 1.74, 95% CI: 1.34-2.25, and p-value < 0.001) (van Doorn et al., 2003) . More recently, a study of 179 subjects aged over 65 conducted in the United Kingdom has shown that the incidence rate of fall was nearly eight times higher in dementia subjects than in controls (incident density ratio ¼ 7.58, 95% CI: 3.11-18.5) (Allan, Ballard, Rowan, & Kenny, 2009 ). Furthermore, multivariate analyses performed in the same study have demonstrated that three variables predicted fall in dementia patients: symptomatic orthostatic hypotension (HR ¼ 2.13, 95% CI: 1.19-3.80), autonomic symptom score (per point HR ¼ 1.055, 95% CI: 1.012-1.099), and Cornell depression score (per point HR ¼ 1.053, 95% CI: 1.01-1.099) (Allan et al., 2009 ).
The hip is one of the commonest sites of fracture. The link between falls and hip fractures is strong and has been studied by a number of authors. As a matter of fact, a Danish study of a retrospective cohort followed between 2000 and 2009 has shown that the incidence of hip fractures decreased over time (787-589 cases per 100,000 individuals for men, and 1758-1275 per 100,000 individuals for women), with this overall trend potentially explained by a reduction in fall-associated comorbidity (Jørgensen et al., 2014) . In addition to the impact of fall on fractures of the hip and other bones, it is important to keep in mind that fracture at one site is itself a risk factor for fracture at the contralateral site (Liu et al., 2015) . As falls may be related to a psychiatric condition, there has been intensive research on the association between dementia (particularly Alzheimer's disease) and the risk of developing fracture. Buchner and Larson were among the first authors to find that the incidence rate of fracture was three times higher in patients with Alzheimer's disease than in sex-and agematched controls (Buchner & Larson, 1987) . In 1994, Melton et al analyzed the impact of Alzheimer's disease onset on fracture risk and showed that there was a twofold increase in fractures in patients newly diagnosed with Alzheimer's disease as compared with age-and sex-matched controls (Melton, Beard, Kokmen, Atkinson, & O'Fallon, 1994) . More recently, a meta-analysis including nine studies published before 2012 has examined the association between Alzheimer's disease and the risk of hip fracture, and found that dementia patients had a lower bone mineral density (standard mean difference equal to À1.12, 95% CI: À1.34-0.90) and were at a higher risk of hip fracture (for dichotomous data: OR ¼ 1.80, 95% CI: 1.54-2.11) than healthy controls (Zhao, Shen, & Ji, 2012) . Apart from these works focusing on Alzheimer's disease, several studies have been carried out on patients with other types of dementia. In 1992, Olof Johnell and colleagues found in a retrospective study of 138 subjects with Parkinson's disease and 138 controls that there was an increased number of fractures in the Parkinson's group (n ¼ 88) as compared with the control group (n ¼ 39) (RR ¼ 2.3, 95% CI: 1.6-3.3) (Johnell, Melton, Atkinson, O'fallon, & Kurland, 1992) . The greatest increase was observed for proximal femur fractures, with 20 and one cases occurring in the Parkinson's and control groups, respectively (RR ¼ 20, 95% CI: 4.0->100). These results have also been confirmed in a case-control study of 174 women from New York and Philadelphia hospitals, although the fracture odds ratio associated with Parkinson's disease was higher (OR ¼ 9.4, 95% CI: 1.2-76.1) (Grisso et al., 1991) . Nonetheless, one has to keep in mind that the second study only considered hip fractures in female patients and included subjects older than those in the first study (80 years versus 72 years) (Grisso et al., 1991; Johnell et al., 1992) . Our work also demonstrated that the incidence of hip fractures was higher in dementia patients living in nursing homes than in those living at home. Indeed, patients living in nursing homes usually display later stages of dementia (moderate to severe), leading to greater motor dysfunction and greater gait impairment than in subjects in earlier stages (O'Keeffe et al., 1996) . Thus, we concluded that home placement was a function of dementia severity. In addition to this relationship, Sato et al. demonstrated in 1998 that patients with Alzheimer's disease living in nursing homes are at a higher risk of sunlight deprivation, 25-hydroxyvitamin D deficiency, and reduction of bone mineral density (BMD) (Sato, Asoh, & Oizumi, 1998) . Later, another work found that low BMD and serum 25-OHD concentrations <5 ng/ml with secondary hyperparathyroidism increase the risk of developing hip fracture in elderly women with dementia (Sato, Kanoko, Satoh, & Iwamoto, 2004) . Our findings are in line with this literature, as we demonstrated that living in nursing homes was a risk factor of bone fracture in dementia.
Moreover, we also showed that osteoporosis increased the chance of fracture. A recent Taiwanese study has discovered that osteoporosis increases the odds of hip fracture in dementia patients (with osteoporosis: HR ¼ 2.27, 95% CI: 1.28-4.01, without osteoporosis: HR ¼ 1.84, 95% CI: 1.37-2.46, both compared with the control group) (Wang et al., 2014) , underlining the importance of osteoporosis treatment and management in subjects with dementia.
Our study also showed that antidementia, antipsychotic, and antidepressant drugs generally had no significant impact on hip fracture risk when prescribed for less than six months. Nonetheless, there was one exception: antipsychotics increased this risk when given to subjects for one month. By contrast, we observed that the chances of hip fracture decreased when these medications were used for more than six months. All these results must be discussed carefully, since several authors have found that such treatments have negative effects on fracture risk. Indeed, in 2009, Gill et al. analyzed the relationship between cholinesterase inhibitors, which are commonly prescribed to treat dementia, and adverse effects associated with syncope, and demonstrated that hip fractures are more frequent among patients receiving these molecules (HR ¼ 1.18, 95% CI: 1.04-1.34) (Gill et al., 2009) . More recent studies with various designs and performed in different countries have returned similar results, corroborating the intriguing relationship between antidementia/antipsychotic drugs and bone fracture (Bakken et al., 2013; Eimar et al., 2013; Tamimi et al., 2012) . Nonetheless, most of these works have not focused to a significant extent on the impact of therapy duration on the risk of bone fracture (Bolton et al., 2008; Liperoti et al., 2007; Ray, Griffin, Schaffner, Baugh, & Melton, 1987) . Therefore, although these drugs initially increase the odds of developing bone fractures, it is still possible that adverse effects disappear after several months and that treatment becomes more effective, leading to a decreased risk of falling and fractures in patients with dementia. A recent trial has shown that Donepezil improves gait in participants with mild Alzheimer's disease (Montero-Odasso et al., 2015) . Since agitation and depressive symptoms increase fall risk, successful and well-tolerated antidepressant therapy could reduce this risk (Kvelde et al., 2015) . Thus, this hypothesis could explain why antidementia, antipsychotic, and antidepressant drugs protected against hip fracture when there were given for more than six months.
This study was subject to several limitations. The major limitation is related to the diagnoses performed by primary care physicians, as neither dementia nor bone fracture can be diagnosed fully. Several factors potentially impacting fracture risk were also missing (i.e. decreased bone density and muscle mass, nutritional problems, or physical inactivity). We did not assess a dose relationship. Furthermore, patients were observed retrospectively in only one practice. Finally, if patients visited another doctor-which is common in Germany-this visit would not be documented.
We showed that dementia increased the risk of hip fracture in primary care practices in Germany. Living in nursing homes also impacted the incidence of fracture. Therefore, German patients with dementia need personalized treatments and management, particularly involving psychiatrists and surgeons or orthopedics, in order to decrease the comorbidity associated with bone fractures.
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